Creating Better Together™
DJO has been part of Colfax Corporation for the past three years, leveraging Colfax’s financial strength and cornerstone principle of continuous improvement to drive growth and innovation.
In the coming weeks, DJO and Colfax will begin the next phase of our remarkable growth journey together – as Enovis, an entirely new public company solely focused on medical technology. Over time, the DJO brand name also will transition to Enovis, which stands for innovation and vision.
What will not change in this transition is our commitment to bringing best-in-class products and technology to market, and a concentrated focus on our customers’ needs, brought to you by the talented team you trust and have depended on for years.
Powered by a culture of continuous improvement, extraordinary talent and innovation, our new name reflects our focused mission of delivering clinically differentiated solutions that generate measurably better outcomes with an unwavering vision of transforming care for the patients you treat.
Innovation + Vision
DJO and Colfax Today. Enovis Tomorrow. Committed to your success always.
In the News
Enovis (formerly Colfax) Completes Spin-off of ESAB Corporation
Enovis and ESAB common stock will each begin regular-way trading today, April 5, 2022, on the New York Stock Exchange under the ticker symbols “ENOV” and “ESAB”, respectively.
Bright Future
Learn more about our new name and exciting future following the planned separation of ESAB in early 2022.
Colfax Announces Board of Directors for Enovis
Colfax Corporation (NYSE: CFX), a leading diversified technology company, announced the future composition of the Board of Directors.
